Be part of the knowledge.™

NeuroFrontiers

Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.

So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.

371

LikeLikedUnlike

Episodes 211-225 of 337

From Assessment to Management: Tackling Catatonia in Schizophrenic Patients
NeuroFrontiers
From Assessment to Management: Tackling Catatonia in Schizophrenic Patients
- Ashley Baker, MSN, PMHNP
  Peer
- Stanley N. Caroff, MD
  Peer
How Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors
NeuroFrontiers
How Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Jagan Pillai, MD, PhD
  Peer
Advancements in Multiple Sclerosis: Insights from the 2024 ACTRIMS Forum
NeuroFrontiers
Advancements in Multiple Sclerosis: Insights from the 2024 ACTRIMS Forum
Exploring the Latest in MS Cognitive Rehabilitation Strategies
NeuroFrontiers
Exploring the Latest in MS Cognitive Rehabilitation Strategies
- Nancy Chiaravalloti, PhD
  Peer
Visionary Insights: Assessing MS-Related Retinal Changes with Adaptive Optics
NeuroFrontiers
Visionary Insights: Assessing MS-Related Retinal Changes with Adaptive Optics
- Daniel Harrison, MD
  Peer
Family Planning Clinical Considerations for Patients with Multiple Sclerosis
NeuroFrontiers
Family Planning Clinical Considerations for Patients with Multiple Sclerosis
- Ashley Baker, MSN, PMHNP
  Peer
- Anna A. Shah, MD
  Peer
advertisement
Unmet Needs in Rehabilitation Research for Multiple Sclerosis
NeuroFrontiers
Unmet Needs in Rehabilitation Research for Multiple Sclerosis
- Robert Motl, PhD
  Peer
MS Research: Using Epigenetic Clocks and Biomarkers to Assess Biological Aging
NeuroFrontiers
MS Research: Using Epigenetic Clocks and Biomarkers to Assess Biological Aging
- Yinan Zhang, MD
  Peer
Telehealth in MS Care: Addressing the Potential for Improvement and Concerns
NeuroFrontiers
Telehealth in MS Care: Addressing the Potential for Improvement and Concerns
- Marisa McGinley, DO
  Peer
Addressing Healthcare Barriers in Patients with Multiple Sclerosis
NeuroFrontiers
Addressing Healthcare Barriers in Patients with Multiple Sclerosis
Toxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
NeuroFrontiers
Toxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
- Andrew Wilner, MD, FACP, FAAN
  Peer
- Marcus E. Peter, PhD
  Peer
Schizophrenia Diagnosis: The Importance of a Collaborative Approach
NeuroFrontiers
Schizophrenia Diagnosis: The Importance of a Collaborative Approach
- Ashley Baker, MSN, PMHNP
  Peer
- Morris Goldman, MD
  Peer
- Dara Sanandaji
  Peer
advertisement
Examining the Role of Toxic Tau Proteins in Alzheimer's Disease
NeuroFrontiers
Examining the Role of Toxic Tau Proteins in Alzheimer's Disease
- Andrew Wilner, MD, FACP, FAAN
  Peer
- George Bloom, PhD
  Peer
New Study Shows EBV-Specific T-Cells Contribute to MS Development
NeuroFrontiers
New Study Shows EBV-Specific T-Cells Contribute to MS Development
- J. William Lindsey
  Peer
A Successful and Safe Stem Cell Therapy for Progressive MS
NeuroFrontiers
A Successful and Safe Stem Cell Therapy for Progressive MS
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Stefano Pluchino, MD, PhD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended